“…These features have often been used to explain their "immune privileged" status in allogeneic hosts. Furthermore, BM-MSCs have been shown to inhibit dendritic cell maturation [44], B cell [45] and T cell proliferation [46] and differentiation [47], impair natural killer cell activity [48], as well as support the generation of suppressive immune cells such as: regulatory T cells (Tregs) [43,49], myeloid derived suppressor cells (MDSCs) and tolerogenic dendritic cells (tDCs) [50]. Combination of many soluble factors are meritorious for immunosuppressive activity of BM-MSCs, such as: indoleamine 2,3-dioxygenase (IDO), inducible nitric oxide synthase (iNOS), cyclooxygenases (COX), metabolite prostaglandin E2 (PGE2), tumor necrosis factor α-induced protein 6 (TSG6), transforming growth factor β (TGF-β), soluble form of HLA-G5 [35,44].…”